AbbVie has signed a definitive agreement to acquire Gilgamesh Pharmaceuticals' lead investigational candidate, bretisilocin, for up to $1.2bn, including an upfront payment and development milestones.

Gilgamesh is back, and he's not alone this time. His ever-faithful partner Enkidu (or at least a Primal that resembles her) is makes her first actual appearance in Final Fantasy 14 after a long while, ...

Oluwatokiloba, a freelance creative writer and editor living in Lagos, strikes a delicate balance between his academic studies at the University of Lagos and his love for writing. He is a voracious ...

Rhenn is a Manila-based content writer with a love for all things geek and pop culture, and science and technology. He graduated BA Journalism degree as a Cum Laude, and has since then pursued making ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. AbbVie has bought a psychedelic compound from a little ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. AbbVie on Monday said it ...

Almost all the patients with depression who received Gilgamesh Pharmaceuticals’ psychedelic drug candidate went into remission, furthering the biotech’s attempt to follow the trail blazed by Johnson & ...

AbbVie has reportedly added Gilgamesh Pharmaceuticals to its shopping list. The Big Pharma teamed up with Gilgamesh last year and, according to Bloomberg, is now in talks about buying the mental ...

We delve into the epic tale of Gilgamesh, the legendary Mesopotamian king. From his incredible strength and bravery to his quest for immortality, the episode explores the timeless themes of friendship ...

During the peculiar Hildibrand Quests in Final Fantays 14, players will have the chance to fight one of the series' most iconic villains: Gilgamesh. The fateful encounter is held at the Battle on the ...